Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Gerald E. Connolly Esophageal Cancer Awareness Act of 2025
Client: ESOPHAGEAL CANCER ACTION NETWORK (ECAN) · Firm: MGD STRATEGIES LLC
Support passage of the Clinical Trials Modernization Act (S. 4440/H.R. 3521) Support passage of the Gerald E. Connolly Esophageal Cancer Awareness Act (HR3490; Public Law No. 119-96)
Clinical Trial Modernization Act
Client: CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION · Firm: MGD STRATEGIES LLC
Support passage of the Clinical Trials Modernization Act (S. 4440/ H.R. 3521)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2026 · second_quarter · Q2
Report language on deadliest cancers in the FY 2027 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2027 LHHSAppropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2027 Defense Appropriations bill
Support for the Clinical Trials Modernization Act (S. 4440/H.R. 3521)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| 8 |
| 2024–2026 |
| SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM | 8 | 2018–2019 |
| NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION | 3 | 2026 |
Clinical Trial Modernization Act
Client: NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Support for the Clinical Trials Modernization Act (S. 4440/H.R. 3521)
Clinical Trial Modernization Act
Client: ESOPHAGEAL CANCER ACTION NETWORK (ECAN) · Firm: MGD STRATEGIES LLC
Support passage of the Clinical Trials Modernization Act (S. 4440/H.R. 3521) Support passage of the Gerald E. Connolly Esophageal Cancer Awareness Act (HR3490; Public Law No. 119-96)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Clinical Trial Modernization Act
Client: CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION · Firm: MGD STRATEGIES LLC
Support passage of the Clinical Trials Modernization Act (S. 4440/ H.R. 3521)
Clinical Trial Modernization Act
Client: NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Support for the Clinical Trials Modernization Act (S. 4440/H.R. 3521)
Clinical Trial Modernization Act
Client: ESOPHAGEAL CANCER ACTION NETWORK (ECAN) · Firm: MGD STRATEGIES LLC
Support passage of the Clinical Trials Modernization Act (S. 4440/H.R. 3521) Support passage of the Gerald E. Connolly Esophageal Cancer Awareness Act (HR3490; Public Law No. 119-96)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Medical Nutrition Equity Act of 2023
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (H.R. 6892)
Medical Nutrition Equity Act of 2023
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (H.R. 6892)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act of 2021
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Cancer Drug Parity Act of 2019
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Cancer Drug Parity Act of 2019
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
CLINICAL TREATMENT Act
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913)
CLINICAL TREATMENT Act
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
CLINICAL TREATMENT Act
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913)
CLINICAL TREATMENT Act
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Cancer Drug Parity Act of 2019
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Cancer Drug Parity Act of 2019
Client: GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
VACCINES Act of 2019
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Support for the VACCINE Act (H.R. 2862)
VACCINES Act of 2019
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Support for the VACCINE Act (H.R. 2862)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 1911/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 1911/H.R. 2587)
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
the Medical Nutrition Equity Act (S. 1194/H.R. 2587)
Medical Nutrition Equity Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 1194/H.R. 2587)
American Miners Pension Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 1911/H.R. 2587)
American Miners Pension Act of 2017
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN · Firm: MGD STRATEGIES LLC
Medical Nutrition Equity Act (S. 1911/H.R. 2587)
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF THE ASM · Firm: MGD STRATEGIES LLC
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2026 · first_quarter · Q1
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHSAppropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill Report language on deadliest cancers in the FY 2027 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2027 LHHSAppropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2027 Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2026 · first_quarter · 1T
Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill Report language on deadliest cancers in the FY 2027 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2027 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2027 Defense Appropriations bill
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2026 · third_quarter · RR
Advocating on behalf of the deadliest cancers, which are defined by the Recalcitrant Cancer Research Act as those with a five-year relative survival rate below 50 percent.
Advocating on behalf of the deadliest cancers, which are defined by the Recalcitrant Cancer Research Act as those with a five-year relative survival rate below 50 percent.
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION via MGD STRATEGIES LLC
2026 · second_quarter · Q2
Support passage of the Clinical Trials Modernization Act (S. 4440/ H.R. 3521)
Inclusion of stomach cancer in the FY 2027 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2027 LHHS Appropriations bill encouraging NCI to focus on stomach cancer
Advocate in support of language in the FY 2027 National Defense Authorization Act authorizing a cost and feasibility study for an h. pylori screening program for military service men and women within the Department of Defense.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2026 · second_quarter · Q2
Support passage of the Clinical Trials Modernization Act (S. 4440/H.R. 3521) Support passage of the Gerald E. Connolly Esophageal Cancer Awareness Act (HR3490; Public Law No. 119-96)
Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill Inclusion of esophageal cancer in the FY 2027 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2027 LHHS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION via MGD STRATEGIES LLC
2026 · first_quarter · Q1
Advocate in support of language in the FY 2026 National Defense Authorization Act authorizing a cost and feasibility study for an h. pylori screening program for military service men and women within the Department of Defense. Advocate in support of language in the FY 2027 National Defense Authorization Act authorizing a cost and feasibility study for an h. pylori screening program for military service men and women within the Department of Defense.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Inclusion of stomach cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill encouraging NCI to focus on stomach cancer Inclusion of stomach cancer in the FY 2027 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2027 LHHS Appropriations bill encouraging NCI to focus on stomach cancer
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2026 · first_quarter · Q1
Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill Inclusion of esophageal cancer in the FY 2027 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2027 LHHS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2026 · first_quarter · Q1
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill Report language on deadliest cancers in the FY 2027 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2027 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2027 Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION via MGD STRATEGIES LLC
2025 · fourth_quarter · Q4
Inclusion of stomach cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill encouraging NCI to focus on stomach cancer
Advocate in support of language in the FY 2026 National Defense Authorization Act authorizing a cost and feasibility study for an h. pylori screening program for military service men and women within the Department of Defense.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2025 · fourth_quarter · Q4
Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2025 · fourth_quarter · Q4
Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION via MGD STRATEGIES LLC
2025 · third_quarter · Q3
Inclusion of stomach cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill encouraging NCI to focus on stomach cancer
Advocate in support of language in the FY 2026 National Defense Authorization Act authorizing a cost and feasibility study for an h. pylori screening program for military service men and women within the Department of Defense.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2025 · third_quarter · Q3
Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2025 · third_quarter · Q3
Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION via MGD STRATEGIES LLC
2025 · second_quarter · Q2
Inclusion of stomach cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2025 LHHS Appropriations bill encouraging NCI to focus on stomach cancer Inclusion of stomach cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill encouraging NCI to focus on stomach cancer
Advocate in support of language in the FY 2026 National Defense Authorization Act authorizing a cost and feasibility study for an h. pylori screening program for military service men and women within the Department of Defense.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2025 · second_quarter · Q2
Inclusion of esophageal cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2025 LHHS Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act encouraging NCI to focus on esophageal cancer Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2025 · second_quarter · Q2
Report language on deadliest cancers in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION via MGD STRATEGIES LLC
2025 · first_quarter · Q1
Inclusion of stomach cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2025 LHHS Appropriations bill encouraging NCI to focus on stomach cancer Inclusion of stomach cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill encouraging NCI to focus on stomach cancer
Advocate in support of language in the FY 2026 National Defense Authorization Act authorizing a cost and feasibility study for an h. pylori screening program for military service men and women within the Department of Defense.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2025 · first_quarter · 1A
Report language on deadliest cancers in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2025 · first_quarter · Q1
Inclusion of esophageal cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2025 LHHS Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act encouraging NCI to focus on esophageal cancer Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2025 · first_quarter · Q1
Report language on deadliest cancers in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION via MGD STRATEGIES LLC
2024 · fourth_quarter · Q4
Advocate in support for FY25 Appropriations bill legislative language in support of a pilot program within the Department of Defense for an h. pylori screening program for military service men and women.
Inclusion of stomach cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2025 LHHS Appropriations bill encouraging NCI to focus on stomach cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2024 · fourth_quarter · Q4
Inclusion of esophageal cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2025 LHHS Appropriations bill encouraging NCI to focus on esophageal cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2024 · fourth_quarter · Q4
Report language in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION via MGD STRATEGIES LLC
2024 · fourth_quarter · RR
Increase federal funding for stomach cancer research Include stomach cancer in the Department of Defense's Peer-Reviewed Cancer Research Program Include language in the National Defense Authorization Act calling for a report on a plan for Helicobacter Pylori (H. pylori) testing for certain members of the Armed Forces
Increase federal funding for stomach cancer research Include stomach cancer in the Department of Defense's Peer-Reviewed Cancer Research Program Include language in the National Defense Authorization Act calling for a report on a plan for Helicobacter Pylori (H. pylori) testing for certain members of the Armed Forces
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2024 · third_quarter · 3T
Introduction and passage of the Medical Nutrition Equity Act
Introduction and passage of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2024 · third_quarter · 3T
Include stomach cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2024 · third_quarter · Q3
Inclusion of esophageal cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2025 LHHS Appropriations bill encouraging NCI to focus on esophageal cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2024 · third_quarter · Q3
Report language in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN via MGD STRATEGIES LLC
2024 · third_quarter · 3T
Medical Nutrition Equity Act (H.R. 6892)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2024 · second_quarter · Q2
Introduction and passage of the Medical Nutrition Equity Act
Introduction and passage of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2024 · second_quarter · Q2
Include stomach cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2024 · second_quarter · Q2
Inclusion of esophageal cancer in the FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2025 LHHS Appropriations bill encouraging NCI to focus on esophageal cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2024 · second_quarter · Q2
Report language in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN via MGD STRATEGIES LLC
2024 · second_quarter · Q2
Medical Nutrition Equity Act (H.R. 6892)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2024 · first_quarter · Q1
Introduction and passage of the Medical Nutrition Equity Act
Introduction and passage of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2024 · first_quarter · Q1
Include stomach cancer in the FY 2024 and FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2024 · first_quarter · Q1
Inclusion of esophageal cancer in the FY 2024 and FY 2025 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2024 · first_quarter · Q1
Report language in the FY 2024 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2024 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2024 Defense Appropriations bill Report language in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill
Meeting with HHS supporting patient access consensus recommendations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2023 · fourth_quarter · Q4
Introduction and passage of the Medical Nutrition Equity Act
Introduction and passage of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2023 · fourth_quarter · Q4
Include stomach cancer in the FY 2024 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2023 · fourth_quarter · Q4
Inclusion of esophageal cancer in the FY 2024 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2023 · fourth_quarter · Q4
Letter to HHS supporting patient access consensus recommendations
Report language in the FY 2024 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2024 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2024 Defense Appropriations bill Supporting Dr. Bertagnolli as NIH Director
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, Vice President of the U.S.
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2023 · third_quarter · Q3
Inclusion of esophageal cancer in the FY 2024 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2023 · third_quarter · Q3
Include stomach cancer in the FY 2024 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2023 · third_quarter · Q3
Introduction and passage of the Medical Nutrition Equity Act
Introduction and passage of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2023 · third_quarter · Q3
Report language in the FY 2024 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2024 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2024 Defense Appropriations bill Supporting Dr. Bertagnolli as NIH Director
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, Vice President of the U.S.
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2023 · second_quarter · Q2
Inclusion of esophageal cancer in the FY 2024 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2023 · second_quarter · Q2
Include stomach cancer in the FY 2024 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2023 · second_quarter · Q2
Introduction and passage of the Medical Nutrition Equity Act
Introduction and passage of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2023 · second_quarter · Q2
Report language in the FY 2024 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2024 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2024 Defense Appropriations bill Supporting Dr. Bertagnolli as NIH Director
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2023 · first_quarter · Q1
Introduction and passage of the Medical Nutrition Equity Act
Introduction and passage of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2023 · first_quarter · Q1
Include stomach cancer in the FY 2024 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2023 · first_quarter · Q1
Inclusion of esophageal cancer in the FY 2024 Department of Defense's Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2023 · first_quarter · Q1
Report language in the FY 2024 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2024 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2024 Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2022 · fourth_quarter · Q4
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2022 · fourth_quarter · Q4
Report language in the FY23 Department of Defense's Appropriations bill to include stomach cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2022 · fourth_quarter · Q4
Report langauge in the FY 2023 Department of Defense Appropriations Bill to include esophageal cancer in the Peer-Reeviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2022 · fourth_quarter · Q4
Authorization of the Advanced Research Projects Agency for Health (ARPA-H)
Report language in the FY 2023 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2023 LHHS Appropriations bill Funding for the Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2022 · third_quarter · Q3
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2022 · third_quarter · Q3
Report language in the FY23 Department of Defense's Appropriations bill to include stomach cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2022 · third_quarter · Q3
Report langauge in the FY 2023 Department of Defense Appropriations Bill to include esophageal cancer in the Peer-Reeviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2022 · third_quarter · Q3
Report language in the FY 2023 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2023 LHHS Appropriations bill Funding for the Advanced Research Projects Agency for Health (ARPA-H)
Authorization of the Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2022 · second_quarter · Q2
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Filing targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2022 · second_quarter · Q2
Report language in the FY23 Department of Defense's Appropriations bill to include stomach cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2022 · second_quarter · Q2
Report langauge in the FY 2023 Department of Defense Appropriations Bill to include esophageal cancer in the Peer-Reeviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2022 · second_quarter · Q2
Authorization of the Advanced Research Projects Agency for Health (ARPA-H)
Report language in the FY 2023 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2023 LHHS Appropriations bill Funding for the Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, Vice President of the U.S.
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2022 · first_quarter · Q1
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2022 · first_quarter · Q1
Report language in the FY22 and FY23 Department of Defense's Appropriations bill to include stomach cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2022 · first_quarter · Q1
Report langauge in the FY 2022 and FY 2023 Department of Defense Appropriations Bill to include esophageal cancer in the Peer-Reeviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2022 · first_quarter · Q1
Authorization of the Advanced Research Projects Agency for Health (ARPA-H)
Report language in the FY 2022 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2022 LHHS Appropriations bill Report language in the FY 2023 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2023 LHHS Appropriations bill Funding for the Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2021 · fourth_quarter · Q4
Report langauge in the FY 2022 Department of Defense Appropriations Bill to include esophageal cancer in the Peer-Reeviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2021 · fourth_quarter · Q4
Report language in the FY22 Department of Defense's Appropriations bill to include stomach cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2021 · fourth_quarter · Q4
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2021 · fourth_quarter · Q4
Report language in the FY 2022 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2022 LHHS Appropriations bill Funding for the Advanced Research Projects Agency for Health (ARPA-H)
Authorization of the Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2021 · third_quarter · Q3
Authorization of the Advanced Research Projects Agency for Health (ARPA-H)
Report language in the FY 2022 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2022 LHHS Appropriations bill Funding for the Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2021 · third_quarter · Q3
Report langauge in the FY 2022 Department of Defense Appropriations Bill to include esophageal cancer in the Peer-Reeviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2021 · third_quarter · Q3
Report language in the FY22 Department of Defense's Appropriations bill to include stomach cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2021 · third_quarter · Q3
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Medical Nutrition Equity Act (S. 2013/H.R. 3783)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2021 · second_quarter · Q2
Report langauge in the FY 2022 Department of Defense Appropriations Bill to include esophageal cancer in the Peer-Reeviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2021 · second_quarter · Q2
Report language in the FY 2022 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2022 LHHS Appropriations bill Funding for the Advanced Research Projects Agency for Health (ARPA-H)
Authorization of the Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2021 · second_quarter · Q2
Medical Nutrition Equity Act
Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2021 · second_quarter · Q2
Report language in the FY22 Department of Defense's Appropriations bill to include stomach cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2021 · first_quarter · Q1
Medical Nutrition Equity Act
Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2021 · first_quarter · Q1
Report language in the FY 2022 LHHS Appropriations bill on deadliest cancers Funding for the National Institutes of Health and the National Cancer Institute in the FY 2022 LHHS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2021 · first_quarter · Q1
Report langauge in the FY 2022 Department of Defense Appropriations Bill to include esophageal cancer in the Peer-Reeviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2021 · first_quarter · Q1
Report language in the FY22 Department of Defense's Appropriations bill to include stomach cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN via MGD STRATEGIES LLC
2021 · first_quarter · Q1
Medical Nutrition Equity Act
Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF PATIENTS & PROVIDER'S FOR MEDICA via MGD STRATEGIES LLC
2021 · first_quarter · RR
coverage for and access to medically necessary nutrition
coverage for and access to medically necessary nutrition
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2020 · fourth_quarter · Q4
Report language in the Department of Defense FY21 Appropriations bills to continue to include stomach cancer in the Peer-Reviewed Cancer Research Program Report language in the Labor, Health & Human Services FY21 Appropriations bills to hold NCI accountable to the language in the FY20 bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2020 · fourth_quarter · Q4
Report language in the Department of Defense FY 2021 Appropriations bills to continue to include esophageal cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2020 · fourth_quarter · Q4
Funding for the NCI in the FY21 Labor, Health & Human Services, & Education bills Report language on the deadliest cancers in the FY21 Labor, Health & Human Services, & Education bills Funding for the Peer Reviewed Cancer Research Program in the FY21 Defense Appropriation bills
Advocating for the Clinical TREATMENT Act (H.R. 913)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN via MGD STRATEGIES LLC
2020 · fourth_quarter · Q4
Co-sponsorship of the Medical Nutrition Equity Act
Co-sponsorship of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2020 · third_quarter · Q3
Report language in the Department of Defense FY 2021 Appropriations bills to continue to include esophageal cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2020 · third_quarter · Q3
Report language in the Department of Defense FY21 Appropriations bills to continue to include stomach cancer in the Peer-Reviewed Cancer Research Program Report language in the Labor, Health & Human Services FY21 Appropriations bills to hold NCI accountable to the language in the FY20 bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF NASPGHAN via MGD STRATEGIES LLC
2020 · third_quarter · Q3
Co-sponsorship of the Medical Nutrition Equity Act
Co-sponsorship of the Medical Nutrition Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION via MGD STRATEGIES LLC
2020 · third_quarter · Q3
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Funding for the NCI in the FY21 Labor, Health & Human Services, & Education bills Report language on the deadliest cancers in the FY21 Labor, Health & Human Services, & Education bills Funding for the Peer Reviewed Cancer Research Program in the FY21 Defense Appropriation bills
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SUMMIT HEALTH CARE CONSULTING, LLC ON BEHALF OF DEBBIE'S DREAM FOUNDATION: CURIN via MGD STRATEGIES LLC
2020 · second_quarter · Q2
Report language in the Department of Defense FY21 Appropriations bills to continue to include stomach cancer in the Peer-Reviewed Cancer Research Program Report language in the Labor, Health & Human Services FY21 Appropriations bills to hold NCI accountable to the language in the FY20 bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) via MGD STRATEGIES LLC
2020 · second_quarter · Q2
Report language in the Department of Defense FY 2021 Appropriations bills to continue to include esophageal cancer in the Peer-Reviewed Cancer Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Increase federal funding for stomach cancer research Include stomach cancer in the Department of Defense's Peer-Reviewed Cancer Research Program Include language in the National Defense Authorization Act calling for a report on a plan for Helicobacter Pylori (H. pylori) testing for certain members of the Armed Forces